Susanna Chan
Podiatrist · Rancho Cucamonga, CANPI 1881004059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $713 and has fallen 53.1% since, to $334 in 2025.
Across 113 payments — averaging $26.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$511
- Smith+Nephew$418
- Paratek Pharmaceuticals, Inc.$344
- Tactile Systems Technology Inc$274
- Bioventus LLC$252
- Stryker$209
- plus $938 from 20 others
What the payments were for
- Food & beverage$2,946100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 5 | $511 |
| Smith+Nephew | 24 | $418 |
| Paratek Pharmaceuticals, Inc. | 16 | $344 |
| Tactile Systems Technology Inc | 17 | $274 |
| Bioventus LLC | 9 | $252 |
| Stryker | 2 | $209 |
| Amgen(2 entities) | 8 | $165 |
| Cardiovascular Systems Inc. | 1 | $96 |
| Melinta Therapeutics, LLC | 4 | $85 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $74 |
| AbbVie | 3 | $60 |
| Medela LLC | 1 | $56 |
| Integra Lifesciences Corporation | 2 | $45 |
| Nabriva Therapeutics, PLC | 2 | $45 |
| Organogenesis Inc. | 1 | $43 |
| Vertex | 2 | $42 |
| KCI USA, Inc. | 2 | $39 |
| Reprise Biomedical, Inc. | 2 | $32 |
| Solventum Corporation | 1 | $31 |
| Nevro Corp. | 1 | $26 |
| Orthofix Medical, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Merck | 1 | $17 |
| DJO, LLC | 1 | $17 |
| Amniox Medical, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$253
- ALLOWRAP$147
- Stravix$125
- Grafix$125
- GrafixPL$125
How this compares
$2,946 in reported general payments places this provider in the 75th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 14 | $1,508 |
| Ciclopirox | 28 | $734 |
| Gentamicin Sulfate | 14 | $677 |
| Ammonium Lactate | 32 | $553 |
| Ketoconazole | 16 | $551 |
| Clotrimazole | 11 | $468 |
| Econazole Nitrate | 12 | $210 |
| Nystatin | 12 | $200 |
| Mupirocin | 27 | $197 |
| Terbinafine Hcl | 13 | $105 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Rancho Cucamonga
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.